251 related articles for article (PubMed ID: 32658596)
21. Oral anticoagulant therapy in atrial fibrillation patients at high stroke and bleeding risk.
Potpara TS; Lip GY
Prog Cardiovasc Dis; 2015; 58(2):177-94. PubMed ID: 26162958
[TBL] [Abstract][Full Text] [Related]
22. Current Strategies for the Management of Bleeding Associated with Direct Oral Anticoagulants and a Review of Investigational Reversal Agents.
Kaide CG; Gulseth MP
J Emerg Med; 2020 Feb; 58(2):217-233. PubMed ID: 31831187
[TBL] [Abstract][Full Text] [Related]
23. Effects of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease: A Systematic Review and Meta-Analysis.
Pan KL; Singer DE; Ovbiagele B; Wu YL; Ahmed MA; Lee M
J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28720644
[TBL] [Abstract][Full Text] [Related]
24. How can we reverse bleeding in patients on direct oral anticoagulants?
Crowther M; Cuker A
Kardiol Pol; 2019; 77(1):3-11. PubMed ID: 30338501
[TBL] [Abstract][Full Text] [Related]
25. Resuming anticoagulation in patients with atrial fibrillation experiencing intracranial hemorrhage.
Wu VC; Huang YC; Chen SW; Liu CH; Chang CW; Chen CC; Chang SH; Lin MS; Lee TH; Chen MC; Hsieh IC; Chu PH; Lin YS
Medicine (Baltimore); 2021 Aug; 100(32):e26945. PubMed ID: 34397946
[TBL] [Abstract][Full Text] [Related]
26. Association of Ischemic Stroke, Major Bleeding, and Other Adverse Events With Warfarin Use vs Non-vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation With a History of Intracranial Hemorrhage.
Tsai CT; Liao JN; Chiang CE; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chung FP; Chao TF; Lip GYH; Chen SA
JAMA Netw Open; 2020 Jun; 3(6):e206424. PubMed ID: 32478848
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
See LC; Lee HF; Chao TF; Li PR; Liu JR; Wu LS; Chang SH; Yeh YH; Kuo CT; Chan YH; Lip GYH
Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
[TBL] [Abstract][Full Text] [Related]
28. Appropriate doses of non-vitamin K antagonist oral anticoagulants in high-risk subgroups with atrial fibrillation: Systematic review and meta-analysis.
Kim IS; Kim HJ; Kim TH; Uhm JS; Joung B; Lee MH; Pak HN
J Cardiol; 2018 Oct; 72(4):284-291. PubMed ID: 29706404
[TBL] [Abstract][Full Text] [Related]
29. Between a rock and a hard place: resumption of oral anticoagulant therapy after intracranial hemorrhage.
Grainger BT; McFadyen JD; Tran H
J Thromb Haemost; 2024 Mar; 22(3):594-603. PubMed ID: 37913910
[TBL] [Abstract][Full Text] [Related]
30. Outcomes Associated With Resuming Warfarin Treatment After Hemorrhagic Stroke or Traumatic Intracranial Hemorrhage in Patients With Atrial Fibrillation.
Nielsen PB; Larsen TB; Skjøth F; Lip GY
JAMA Intern Med; 2017 Apr; 177(4):563-570. PubMed ID: 28241151
[TBL] [Abstract][Full Text] [Related]
31. Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs.
Poli D; Antonucci E; Vignini E; Martinese L; Testa S; Simioni P; Pengo V; Pignatelli P; Falanga A; Masciocco L; Barcellona D; Ciampa A; Chiarugi P; Paparo C; Ageno W; Palareti G;
Eur J Intern Med; 2020 Oct; 80():73-77. PubMed ID: 32522446
[TBL] [Abstract][Full Text] [Related]
32. Retrospective review of Andexanet Alfa versus 4-Factor Prothrombin Complex Concentrate for reversal of DOAC-Associated Intracranial Hemorrhage.
Troyer C; Nguyen W; Xie A; Wimer D
J Thromb Thrombolysis; 2023 Jan; 55(1):149-155. PubMed ID: 36355324
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology and outcomes of intracerebral hemorrhage associated with oral anticoagulation over 10 years in a population-based stroke registry.
Gabriele F; Foschi M; Conversi F; Ciuffini D; De Santis F; Orlandi B; De Santis F; Ornello R; Sacco S
Int J Stroke; 2024 Jun; 19(5):515-525. PubMed ID: 37997897
[TBL] [Abstract][Full Text] [Related]
34. Sex-Based Differences in Outcomes of Oral Anticoagulation in Patients With Atrial Fibrillation.
Law SWY; Lau WCY; Wong ICK; Lip GYH; Mok MT; Siu CW; Chan EW
J Am Coll Cardiol; 2018 Jul; 72(3):271-282. PubMed ID: 30012320
[TBL] [Abstract][Full Text] [Related]
35. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
[TBL] [Abstract][Full Text] [Related]
36. Time to oral anticoagulant reversal in intracranial hemorrhage with an emergency medicine pharmacist presence.
Hutcheson B; Spetz S; Davenport J; Shuler E
Am J Emerg Med; 2024 Jun; 80():114-118. PubMed ID: 38547626
[TBL] [Abstract][Full Text] [Related]
37. Postoperative Strokes and Intracranial Bleeds in Patients With Atrial Fibrillation: The FibStroke Study.
Palomäki A; Kiviniemi T; Hartikainen JE; Mustonen P; Ylitalo A; Nuotio I; Hartikainen P; Jaakkola J; Luite R; Airaksinen KE
Clin Cardiol; 2016 Aug; 39(8):471-6. PubMed ID: 27240121
[TBL] [Abstract][Full Text] [Related]
38. Periprocedural Outcomes of Direct Oral Anticoagulants Versus Warfarin in Nonvalvular Atrial Fibrillation.
Nazha B; Pandya B; Cohen J; Zhang M; Lopes RD; Garcia DA; Sherwood MW; Spyropoulos AC
Circulation; 2018 Oct; 138(14):1402-1411. PubMed ID: 29794081
[TBL] [Abstract][Full Text] [Related]
39. Clinical Stroke prevention in atrial fibrillation.
Voukalis C; Shantsila E; Lip GY
J R Coll Physicians Edinb; 2017 Mar; 47(1):13-23. PubMed ID: 28569277
[TBL] [Abstract][Full Text] [Related]
40. Direct oral anticoagulants (DOAC) - Management of emergency situations.
Lindhoff-Last E
Hamostaseologie; 2017; 37(4):257-266. PubMed ID: 29582928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
